VAPOTHERM INC (VAPO) Stock Price, Forecast & Analysis
USA - NYSE:VAPO - US9221073052 - Common Stock
VAPO Key Statistics, Chart & Performance
The current stock price of VAPO is 1.27 USD. In the past month the price decreased by -49.6%. In the past year, price decreased by -90.44%.
VAPO Latest News, Press Relases and Analysis
VAPO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.21 | 218.95B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.58 | 193.16B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.51 | 146.46B | ||
| SYK | STRYKER CORP | 27.53 | 138.63B | ||
| MDT | MEDTRONIC PLC | 16.35 | 115.98B | ||
| IDXX | IDEXX LABORATORIES INC | 57.27 | 57.77B | ||
| BDX | BECTON DICKINSON AND CO | 12.55 | 51.32B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.74 | 49.40B | ||
| RMD | RESMED INC | 24.89 | 35.96B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.19 | 33.92B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.88 | 26.98B | ||
| DXCM | DEXCOM INC | 32.89 | 23.99B |
Related stock screener links
About VAPO
Company Profile
Vapotherm Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Exeter, New Hampshire and currently employs 261 full-time employees. The company went IPO on 2018-11-14. Vapotherm, Inc. is a medical technology company. The company is focused on the care of patients of all ages suffering from the respiratory distress associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma and COVID-19. Its device solutions are focused on high velocity nasal insufflation (HVNI), which delivers non-invasive ventilatory support to patients suffering from respiratory distress. Its HVNI technology delivers heated, humidified and oxygenated air at a high velocity through a small-bore nasal interface. The company has five versions of its Precision Flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its High Velocity Therapy systems include a capital unit, a single-use disposable and a nasal interface. Its Precision Flow Hi-VNI system offers connectivity to a hospital’s nurse call system to alert the staff to disruption of the patient’s respiratory support.
Company Info
VAPOTHERM INC
100 Domain Drive
Exeter NEW HAMPSHIRE 03833 US
CEO: Joseph Army
Employees: 261
Phone: 16036580411
VAPOTHERM INC / VAPO FAQ
Can you describe the business of VAPOTHERM INC?
Vapotherm Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Exeter, New Hampshire and currently employs 261 full-time employees. The company went IPO on 2018-11-14. Vapotherm, Inc. is a medical technology company. The company is focused on the care of patients of all ages suffering from the respiratory distress associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma and COVID-19. Its device solutions are focused on high velocity nasal insufflation (HVNI), which delivers non-invasive ventilatory support to patients suffering from respiratory distress. Its HVNI technology delivers heated, humidified and oxygenated air at a high velocity through a small-bore nasal interface. The company has five versions of its Precision Flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its High Velocity Therapy systems include a capital unit, a single-use disposable and a nasal interface. Its Precision Flow Hi-VNI system offers connectivity to a hospital’s nurse call system to alert the staff to disruption of the patient’s respiratory support.
What is the stock price of VAPOTHERM INC today?
The current stock price of VAPO is 1.27 USD. The price increased by 6.72% in the last trading session.
What is the dividend status of VAPOTHERM INC?
VAPO does not pay a dividend.
How is the ChartMill rating for VAPOTHERM INC?
VAPO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the growth outlook for VAPOTHERM INC?
The Revenue of VAPOTHERM INC (VAPO) is expected to grow by 5.53% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Who owns VAPOTHERM INC?
You can find the ownership structure of VAPOTHERM INC (VAPO) on the Ownership tab.
VAPO Technical Analysis
VAPO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VAPO. VAPO may be in some trouble as it scores bad on both profitability and health.
VAPO Financial Highlights
Over the last trailing twelve months VAPO reported a non-GAAP Earnings per Share(EPS) of -14.54. The EPS increased by 34.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -86.17% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
VAPO Forecast & Estimates
8 analysts have analysed VAPO and the average price target is 1.02 USD. This implies a price decrease of -19.69% is expected in the next year compared to the current price of 1.27.
For the next year, analysts expect an EPS growth of 81.61% and a revenue growth 5.53% for VAPO